Valid

YY 0861-2011Ophthalmic optics - Ophthalmic viscosurgical devices (English PDF)

眼科光学 眼用粘弹剂

Preview PDF

This is a limited preview

Buy now to download the full PDF (15 pages)

Need quotation for your management?

Get a formal quotation for YY 0861-2011 in 30 minutes.

Issued by

NMPA

Level / Type

Industry · Mandatory

Issue date

December 31, 2011

Implementation date

June 1, 2013

Scope

YY 0861-2011 is the English-translated version of 眼科光学 眼用粘弹剂.

YY 0861-2011 is the Chinese standard "Ophthalmic optics - Ophthalmic viscosurgical devices".

Its scope clause reads: This standard specifies requirements with regard to safety for the intended performance, design attributes, design evaluation, sterilization, product packaging, product labelling and information supplied by the manufacturer of ophthalmic viscosurgical devices.

This standard is applicable to ophthalmic viscosurgical devices (OVDs), a class of substances with viscous and/or viscoelastic properties, intended for use during surgery in the anterior segment of the human eye.

OVDs are designed to create and maintain space, to protect intra-ocular tissues and to manipulate tissues during surgery. Its clauses include terms and definitions.

Found what you need?

Document preview — YY 0861-2011

National Standard of the People's Republic of China

Issued by: National Medical Products Administration of the People's Republic of China

Contents

  • Foreword i
  • 1 Scope
  • 2 Normative references
  • 3 Terms and definitions
  • 4 Intended performance
  • 5 Design characteristics
  • 6 Design evaluation
  • 7 Sterilization
  • 8 Product stability
  • 9 Integrity and performance of delivery system
  • 10 Packaging
  • 11 Information to be supplied by the manufacturer
  • Annex A (Normative) Intraocular implantation test
  • Annex B (Informative) Clinical evaluation
  • Annex C (Informative) Comparison between this standard and ISO 15798: 2010 in clause/subclause number
  • Annex D (Informative) Technical differences between this standard and ISO 15798: 2010 and their reasons

1 Scope

This standard specifies requirements with regard to safety for the intended performance, design attributes, design evaluation, sterilization, product packaging, product labelling and information supplied by the manufacturer of ophthalmic viscosurgical devices.

This standard is applicable to ophthalmic viscosurgical devices (OVDs), a class of substances with viscous and/or viscoelastic properties, intended for use during surgery in the anterior segment of the human eye. OVDs are designed to create and maintain space, to protect intra-ocular tissues and to manipulate tissues during surgery.

2 Normative references

The following referenced documents are indispensable for the application of this document. For dated references, only the edition cited applies. For undated references, the latest edition of the referenced document (including any amendments) applies.

GB/T 16886.1 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (GB/T16886.1-2011; ISO 10993-1: 2009, IDT)

GB/T 16886.2 Biological evaluation of medical devices - Part 2: Animal welfare requirements (GB/T 16886.2-2011; ISO 10993-2: 2009, IDT)

GB/T 16886.5 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (GB/T 16886.5-2003; ISO 10993-5: 1999, IDT)

GB/T 16886.6 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation (GB/T 16886.6-1997; ISO 10993-6: 1994, IDT)

GB/T 16886.9 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (GB/T 16886.9-2001; ISO 10993-9: 1999, IDT)

GB/T 16886.10 Biological evaluation of medical devices - Part 10: Tests for irritation and delayed-type hypersensitivity (GB/T 16886.10-2005; ISO 10993-10: 2002, IDT)

GB/T 16886.16 Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (GB/T 16886.16-2003; ISO 10993-16: 1997, IDT)

GB/T 19633 Packaging for terminally sterilized medical devices (GB/T 19633-2005; ISO 11607: 2003, IDT)

YY/T 0297 Clinical investigation of medical devices (YY/T 0297-1997; ISO 14155: 1996, IDT)

YY/T 0316 Medical devices - Application of risk management to medical devices (YY/T 0316-2008; ISO 14971: 2007, IDT)

YY/T 0466.1 Medical devices- Symbols to be used with medical device labels, labelling and information to be supplied - Part 1: General requirements (YY/T 0466.1-2009; ISO 15223-1: 2007, IDT)

YY/T 0640 Non-active surgical implants - General requirements (YY/T 0640-2008; ISO 14630: 2005, IDT)

YY/T 0771.1-2009 Medical devices utilizing animal tissues and their derivatives - Part 1: Application of risk management (ISO 22442-1: 2007, IDT)

YY/T 0771.2-2009 Medical devices utilizing animal tissues and their derivatives - Part 2:Controls on sourcing, collection and handling (ISO 22442-2: 2007, IDT)

YY/T 0771.3-2009 Medical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or inactivation of viruses and Transmissible Spongiform Encephalopathy (TSE) agents (ISO 22442-3: 2007, IDT)

Pharmacopoeia of the People's Republic of China (2010 Edition, Volume II)

3 Terms and definitions

For the purposes of this document, the following terms and definitions apply.

3.1 complex viscosity

eta*=eta'-i·eta" viscosity consisting of a viscous eta' and an elastic eta'' component where i is an imaginary number defined by

3.2 absolute complex viscosity

absolute value of complex viscosity (3.1)

Note: Absolute complex viscosity is expressed in Pa·s.

......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 15 pages — is available in the English PDF.

Similar standards

How to Download YY 0861-2011

  1. 1

    Add to cart

    Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.

  2. 2

    Checkout

    Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).

  3. 3

    Fast delivery

    After payment you'll receive an email confirmation. The English PDF is sent to the same address, usually within minutes and at the latest within 1 business day.

  4. 4

    Invoice included

    A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.

Related Standards

English PDF
15 pages
Fast delivery
Invoice included
View Cart

Secure payment via Stripe

Payments accepted

VisaMastercardAmerican ExpressApple PayGoogle PayStripe

YY 0861-2011

$255.00